Richard Burr: “I very much look forward to another productive year in this subcommittee with you.”

Ms. Kotagal's refusal to continue these common-sense measures speaks volumes of her lack of commitment to due process and transparency.

I was surprised and frustrated to hear that these funds were overwhelmingly repurposed from within ASPR, including the stockpile.

There is no Member that has defended the FDA more than this one and there is no Member in Congress that has tried to fix areas when they are broken than this one.

Not a single one of our Republican colleagues voted for it.